About this trial
The goal of this clinical trial is to asses the effect of Coenzyme Q10 administration in patients from any gender group who are older than 18 years old undergoing wisdom tooth extraction. The main questions it aims to answer are:
does Coenzyme Q10 help with better tissue healing? does Coenzyme Q10 administration lower the prevalence of Dry socket after surgery? does Coenzyme Q10 prevent TMD (Temporomandibular disorders) while recovering from surgery? how does Coenzyme Q10 administration effect the answers to SF-36 health survey in patients? Researchers will compare Coenzyme Q10 to a placebo (a look-alike substance that contains no drug) to see if it has any effect on mentioned parameters.
Participants will:
* take coenzyme Q10 (100mg) daily for 30 days after surgery. * will be examined and evaluated 1, 7, 14 and 30 days after completion of surgery.
Eligibility criteria
Qualifiers
Patients older than 18 years old that require mandibular or maxillary molar, third tooth extraction as Oral and Maxillofacial surgeon's clinical diagnosis.
Disqualifiers
The patient's departure from Sanandaj
The patient's disagreement with the study protocol
The Patient's demise
The patient's hospitalization for unrelated illnesses
Trial design
Treatments tested in this trial
- Coenzyme Q10 100 MG Oral Tablet
- Placebo
Treatment groups
Locations
Sponsors and collaborators
Zahra Nejati
Lead sponsor
Kurdistan University of Medical Sciences
Sponsor institution
Kurdistan University of Medical Sciences
Collaborator
Hady Mohammadi, Director of oral and maxillofacial surgery department, school of dentistry, Kurdistan university of medical sciences
Collaborator
Yousef Moradi, Assistant professor, Department of epidemiology and biostatistics, Kurdistan university of medical sciences
Collaborator
Babak Ghadirzadeh, medical student, Kurdistan university of medical sciences
Collaborator